China Universal Asset Management Co., Ltd. Merus N.V. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Merus N.V. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 14,517 shares of MRUS stock, worth $627,279. This represents 0.06% of its overall portfolio holdings.
Number of Shares
14,517
Previous 13,119
10.66%
Holding current value
$627,279
Previous $655,000
6.87%
% of portfolio
0.06%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding MRUS
# of Institutions
201Shares Held
57.2MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$180 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$167 Million16.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$128 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$115 Million1.81% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.13MShares$91.8 Million1.3% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.98B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...